Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator
Background This study aimed to investigate the miR‐192 levels in patients' sera of liver fluke‐associated cholangiocarcinoma (CCA) for a prospective prognostic indicator. Methods MicroRNA polymerase chain reaction (PCR) array was performed using pooled serum samples from 11 CCA patients and nin...
Saved in:
| Published in | Journal of hepato-biliary-pancreatic sciences Vol. 21; no. 12; pp. 864 - 872 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Japan
Blackwell Publishing Ltd
01.12.2014
Wiley Subscription Services, Inc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1868-6974 1868-6982 1868-6982 |
| DOI | 10.1002/jhbp.145 |
Cover
| Abstract | Background
This study aimed to investigate the miR‐192 levels in patients' sera of liver fluke‐associated cholangiocarcinoma (CCA) for a prospective prognostic indicator.
Methods
MicroRNA polymerase chain reaction (PCR) array was performed using pooled serum samples from 11 CCA patients and nine healthy subjects. Selected miRNAs were verified for the differential levels in both sera and tumor tissues (of patients and Opisthorchis viverrini (Ov)‐induced CCA model) using TaqMan miRNA expression assay.
Results
Our results demonstrated that miR‐192 was significantly higher in the serum of CCA patients than that in healthy subjects giving a sensitivity of 74% and specificity of 72% (area under the curve [AUC] = 0.803; 95% confidence interval [CI], 0.708–0.897, P < 0.0001). Serum miR‐192 examined in Ov infected subjects and subjects with periductal fibrosis were increased but not statistically significantly when compared with healthy subjects. High levels of serum miR‐192 were significantly correlated with lymph node metastasis (P = 0.047) and shorter survival compared with individuals with low levels of serum miR‐192 (hazard ratio [HR] 2.076, 95% CI 1.004–4.291, P = 0.049). We also found that the expression levels of miR‐192 appeared to be elevated in both CCA tissues of patients and in Ov‐induced CCA tissues of a hamster model.
Conclusions
This finding indicates that elevated levels of miR‐192 may be involved in CCA genesis and have a potential utility as a noninvasive prognostic indicator for CCA patients. |
|---|---|
| AbstractList | Background
This study aimed to investigate the miR‐192 levels in patients' sera of liver fluke‐associated cholangiocarcinoma (CCA) for a prospective prognostic indicator.
Methods
MicroRNA polymerase chain reaction (PCR) array was performed using pooled serum samples from 11 CCA patients and nine healthy subjects. Selected miRNAs were verified for the differential levels in both sera and tumor tissues (of patients and Opisthorchis viverrini (Ov)‐induced CCA model) using TaqMan miRNA expression assay.
Results
Our results demonstrated that miR‐192 was significantly higher in the serum of CCA patients than that in healthy subjects giving a sensitivity of 74% and specificity of 72% (area under the curve [AUC] = 0.803; 95% confidence interval [CI], 0.708–0.897, P < 0.0001). Serum miR‐192 examined in Ov infected subjects and subjects with periductal fibrosis were increased but not statistically significantly when compared with healthy subjects. High levels of serum miR‐192 were significantly correlated with lymph node metastasis (P = 0.047) and shorter survival compared with individuals with low levels of serum miR‐192 (hazard ratio [HR] 2.076, 95% CI 1.004–4.291, P = 0.049). We also found that the expression levels of miR‐192 appeared to be elevated in both CCA tissues of patients and in Ov‐induced CCA tissues of a hamster model.
Conclusions
This finding indicates that elevated levels of miR‐192 may be involved in CCA genesis and have a potential utility as a noninvasive prognostic indicator for CCA patients. This study aimed to investigate the miR-192 levels in patients' sera of liver fluke-associated cholangiocarcinoma (CCA) for a prospective prognostic indicator. MicroRNA polymerase chain reaction (PCR) array was performed using pooled serum samples from 11 CCA patients and nine healthy subjects. Selected miRNAs were verified for the differential levels in both sera and tumor tissues (of patients and Opisthorchis viverrini (Ov)-induced CCA model) using TaqMan miRNA expression assay. Our results demonstrated that miR-192 was significantly higher in the serum of CCA patients than that in healthy subjects giving a sensitivity of 74% and specificity of 72% (area under the curve [AUC] = 0.803; 95% confidence interval [CI], 0.708-0.897, P < 0.0001). Serum miR-192 examined in Ov infected subjects and subjects with periductal fibrosis were increased but not statistically significantly when compared with healthy subjects. High levels of serum miR-192 were significantly correlated with lymph node metastasis (P = 0.047) and shorter survival compared with individuals with low levels of serum miR-192 (hazard ratio [HR] 2.076, 95% CI 1.004-4.291, P = 0.049). We also found that the expression levels of miR-192 appeared to be elevated in both CCA tissues of patients and in Ov-induced CCA tissues of a hamster model. This finding indicates that elevated levels of miR-192 may be involved in CCA genesis and have a potential utility as a noninvasive prognostic indicator for CCA patients. Background This study aimed to investigate the miR-192 levels in patients' sera of liver fluke-associated cholangiocarcinoma (CCA) for a prospective prognostic indicator. Methods MicroRNA polymerase chain reaction (PCR) array was performed using pooled serum samples from 11 CCA patients and nine healthy subjects. Selected miRNAs were verified for the differential levels in both sera and tumor tissues (of patients and Opisthorchis viverrini (Ov)-induced CCA model) using TaqMan miRNA expression assay. Results Our results demonstrated that miR-192 was significantly higher in the serum of CCA patients than that in healthy subjects giving a sensitivity of 74% and specificity of 72% (area under the curve [AUC] = 0.803; 95% confidence interval [CI], 0.708-0.897, P < 0.0001). Serum miR-192 examined in Ov infected subjects and subjects with periductal fibrosis were increased but not statistically significantly when compared with healthy subjects. High levels of serum miR-192 were significantly correlated with lymph node metastasis (P = 0.047) and shorter survival compared with individuals with low levels of serum miR-192 (hazard ratio [HR] 2.076, 95% CI 1.004-4.291, P = 0.049). We also found that the expression levels of miR-192 appeared to be elevated in both CCA tissues of patients and in Ov-induced CCA tissues of a hamster model. Conclusions This finding indicates that elevated levels of miR-192 may be involved in CCA genesis and have a potential utility as a noninvasive prognostic indicator for CCA patients. This study aimed to investigate the miR-192 levels in patients' sera of liver fluke-associated cholangiocarcinoma (CCA) for a prospective prognostic indicator.BACKGROUNDThis study aimed to investigate the miR-192 levels in patients' sera of liver fluke-associated cholangiocarcinoma (CCA) for a prospective prognostic indicator.MicroRNA polymerase chain reaction (PCR) array was performed using pooled serum samples from 11 CCA patients and nine healthy subjects. Selected miRNAs were verified for the differential levels in both sera and tumor tissues (of patients and Opisthorchis viverrini (Ov)-induced CCA model) using TaqMan miRNA expression assay.METHODSMicroRNA polymerase chain reaction (PCR) array was performed using pooled serum samples from 11 CCA patients and nine healthy subjects. Selected miRNAs were verified for the differential levels in both sera and tumor tissues (of patients and Opisthorchis viverrini (Ov)-induced CCA model) using TaqMan miRNA expression assay.Our results demonstrated that miR-192 was significantly higher in the serum of CCA patients than that in healthy subjects giving a sensitivity of 74% and specificity of 72% (area under the curve [AUC] = 0.803; 95% confidence interval [CI], 0.708-0.897, P < 0.0001). Serum miR-192 examined in Ov infected subjects and subjects with periductal fibrosis were increased but not statistically significantly when compared with healthy subjects. High levels of serum miR-192 were significantly correlated with lymph node metastasis (P = 0.047) and shorter survival compared with individuals with low levels of serum miR-192 (hazard ratio [HR] 2.076, 95% CI 1.004-4.291, P = 0.049). We also found that the expression levels of miR-192 appeared to be elevated in both CCA tissues of patients and in Ov-induced CCA tissues of a hamster model.RESULTSOur results demonstrated that miR-192 was significantly higher in the serum of CCA patients than that in healthy subjects giving a sensitivity of 74% and specificity of 72% (area under the curve [AUC] = 0.803; 95% confidence interval [CI], 0.708-0.897, P < 0.0001). Serum miR-192 examined in Ov infected subjects and subjects with periductal fibrosis were increased but not statistically significantly when compared with healthy subjects. High levels of serum miR-192 were significantly correlated with lymph node metastasis (P = 0.047) and shorter survival compared with individuals with low levels of serum miR-192 (hazard ratio [HR] 2.076, 95% CI 1.004-4.291, P = 0.049). We also found that the expression levels of miR-192 appeared to be elevated in both CCA tissues of patients and in Ov-induced CCA tissues of a hamster model.This finding indicates that elevated levels of miR-192 may be involved in CCA genesis and have a potential utility as a noninvasive prognostic indicator for CCA patients.CONCLUSIONSThis finding indicates that elevated levels of miR-192 may be involved in CCA genesis and have a potential utility as a noninvasive prognostic indicator for CCA patients. |
| Author | Loilome, Watcharin Pairojkul, Chawalit Silakit, Runglawan Khuntikeo, Narong Chamadol, Nittaya Namwat, Nisana Yongvanit, Puangrat Chusorn, Porncheera Boonmars, Thidarut Techasen, Anchalee |
| Author_xml | – sequence: 1 givenname: Runglawan surname: Silakit fullname: Silakit, Runglawan email: nisana@kku.ac.th organization: Department of Biochemistry, Faculty of Medicine, Khon Kaen University, 123 Mitraparb Road, 40002, Khon Kaen, Thailand – sequence: 2 givenname: Watcharin surname: Loilome fullname: Loilome, Watcharin organization: Department of Biochemistry, Faculty of Medicine, Khon Kaen University, 123 Mitraparb Road, 40002, Khon Kaen, Thailand – sequence: 3 givenname: Puangrat surname: Yongvanit fullname: Yongvanit, Puangrat organization: Department of Biochemistry, Faculty of Medicine, Khon Kaen University, 123 Mitraparb Road, 40002, Khon Kaen, Thailand – sequence: 4 givenname: Porncheera surname: Chusorn fullname: Chusorn, Porncheera organization: Department of Biochemistry, Faculty of Medicine, Khon Kaen University, 123 Mitraparb Road, 40002, Khon Kaen, Thailand – sequence: 5 givenname: Anchalee surname: Techasen fullname: Techasen, Anchalee organization: Center for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Science, Khon Kaen University, Khon Kaen, Thailand – sequence: 6 givenname: Thidarut surname: Boonmars fullname: Boonmars, Thidarut organization: Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand – sequence: 7 givenname: Narong surname: Khuntikeo fullname: Khuntikeo, Narong organization: Department of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand – sequence: 8 givenname: Nittaya surname: Chamadol fullname: Chamadol, Nittaya organization: Department of Radiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand – sequence: 9 givenname: Chawalit surname: Pairojkul fullname: Pairojkul, Chawalit organization: Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand – sequence: 10 givenname: Nisana surname: Namwat fullname: Namwat, Nisana organization: Department of Biochemistry, Faculty of Medicine, Khon Kaen University, 123 Mitraparb Road, 40002, Khon Kaen, Thailand |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25131257$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kUtv1DAUhS3Uij6oxC9AkdiwydTPOGEHo7YDlId4Li3HuZl6mthT2wH67_Fo2kEg8MZn8Z2jo3uO0J7zDhB6TPCMYExPV1fteka4eIAOSV3VZdXUdG-nJT9AJzGucH6MsIbhh-iACsIIFfIQjXMbzDToZN2yGO3HkjS0sK4Y7HcIRT9M11DqGL2xOkFXmCs_aLe03uhgrPOjLtbZCy7F50XWwcc1mJTNG710PiZrcl5njU4-PEL7vR4inNz9x-jL-dnn-aK8fH_xav7isjRcSlHKTkPbkxZ0xeu2qjnh0LS0IsLQrq06xkFKTFjdGay5obzpqBam4hhE30nJjtGzbW4ucTNBTGq00cCQu4OfoiIVlVjWjGzQp3-hKz8Fl9spkrsIwjnDmXpyR03tCJ1aBzvqcKvuD5mB2RYw-QQxQK-MTfky3qWg7aAIVpux1GYslcf6XXFnuM_8B1pu0R92gNv_cur14uWHP3gbE_zc8Tpcq0oyKdS3dxfqrZD009fFGzVnvwAL-rKF |
| CitedBy_id | crossref_primary_10_18632_oncotarget_19044 crossref_primary_10_1016_j_exppara_2023_108551 crossref_primary_10_1155_2016_4805270 crossref_primary_10_3389_fvets_2022_1018872 crossref_primary_10_18632_aging_102634 crossref_primary_10_1042_CS20160216 crossref_primary_10_1007_s11686_021_00444_x crossref_primary_10_3390_jcm4091688 crossref_primary_10_1016_j_clinre_2015_10_001 crossref_primary_10_1017_S0031182017000300 crossref_primary_10_3748_wjg_v28_i15_1508 crossref_primary_10_1007_s11686_022_00641_2 crossref_primary_10_1152_ajpgi_00297_2015 crossref_primary_10_4251_wjgo_v9_i7_268 crossref_primary_10_1016_j_biopha_2016_02_045 crossref_primary_10_1155_2016_9797410 crossref_primary_10_1016_j_clinre_2016_10_007 crossref_primary_10_3390_cancers14041026 crossref_primary_10_4103_0973_1482_193125 crossref_primary_10_1016_j_pt_2015_09_003 crossref_primary_10_1016_j_suronc_2022_101851 crossref_primary_10_12688_f1000research_11371_1 crossref_primary_10_4251_wjgo_v13_i5_332 crossref_primary_10_1016_j_suronc_2016_12_009 crossref_primary_10_3389_fonc_2021_768009 crossref_primary_10_18632_oncotarget_13929 crossref_primary_10_3390_cancers13133222 crossref_primary_10_1007_s12010_019_03177_w crossref_primary_10_3390_ijms17050791 crossref_primary_10_1016_j_bbadis_2017_06_026 crossref_primary_10_1016_j_vetpar_2023_110075 crossref_primary_10_1007_s10096_019_03715_8 crossref_primary_10_1002_gcc_22889 crossref_primary_10_1080_14737159_2023_2178903 crossref_primary_10_1007_s13277_016_5313_6 crossref_primary_10_2217_hep_2015_0003 crossref_primary_10_3390_cancers13010012 crossref_primary_10_3390_biom10101377 crossref_primary_10_7717_peerj_18367 crossref_primary_10_4174_astr_2021_101_3_140 crossref_primary_10_1016_j_molbiopara_2024_111636 crossref_primary_10_1111_liv_14090 crossref_primary_10_1038_s41598_019_42392_7 crossref_primary_10_1016_j_jhep_2016_06_016 crossref_primary_10_1016_j_bbadis_2017_08_002 crossref_primary_10_1155_2021_8851035 crossref_primary_10_1016_j_actatropica_2018_02_031 crossref_primary_10_1016_j_dld_2016_07_006 crossref_primary_10_1016_j_parint_2015_10_001 crossref_primary_10_1159_000488342 crossref_primary_10_1007_s12026_018_9041_4 crossref_primary_10_1016_j_pt_2023_07_001 crossref_primary_10_1038_s41575_020_0310_z crossref_primary_10_1016_j_actatropica_2019_105255 crossref_primary_10_1186_s12935_025_03666_5 crossref_primary_10_1016_j_isci_2024_111437 crossref_primary_10_3390_ijms22147627 |
| Cites_doi | 10.1002/jhbp.64 10.1371/journal.pone.0005532 10.1038/sj.onc.1210648 10.1016/j.canlet.2011.10.034 10.1146/annurev.pathol.4.110807.092222 10.1161/CIRCRESAHA.113.301209 10.1111/j.1365-3156.2004.01234.x 10.1136/gut.2008.167817 10.1002/pros.22495 10.1016/j.jhep.2008.09.015 10.1016/j.parint.2011.06.011 10.1038/sj.bjc.6605833 10.3892/or.2013.2420 10.1016/j.canlet.2006.05.007 10.1016/S0092-8674(04)00045-5 10.1073/pnas.0804549105 10.1016/j.pt.2012.07.006 10.1186/1746-1596-6-114 10.1038/onc.2010.534 10.1007/s10620-005-2927-8 10.1245/s10434-010-1188-8 10.1038/modpathol.3880310 10.1053/j.gastro.2006.02.057 10.1002/hep.24538 10.1002/hep.23381 10.1146/annurev.med.59.053006.104707 10.1097/JTO.0b013e318208c785 10.1038/bjc.2013.8 10.1681/ASN.2010020134 10.1007/s13277-013-0688-0 10.1038/cr.2008.282 10.1136/gut.2007.138859 10.1200/JCO.2011.38.2697 10.1002/cncr.25912 10.1053/j.gastro.2012.03.045 10.1002/hep.22838 10.1016/j.mrfmmm.2010.06.003 |
| ContentType | Journal Article |
| Copyright | 2014 Japanese Society of Hepato‐Biliary‐Pancreatic Surgery 2014 Japanese Society of Hepato-Biliary-Pancreatic Surgery. Copyright © 2014 Royal Pharmaceutical Society |
| Copyright_xml | – notice: 2014 Japanese Society of Hepato‐Biliary‐Pancreatic Surgery – notice: 2014 Japanese Society of Hepato-Biliary-Pancreatic Surgery. – notice: Copyright © 2014 Royal Pharmaceutical Society |
| DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
| DOI | 10.1002/jhbp.145 |
| DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 1868-6982 |
| EndPage | 872 |
| ExternalDocumentID | 3996463201 25131257 10_1002_jhbp_145 JHBP145 ark_67375_WNG_M572SVHK_C |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Thailand |
| GeographicLocations_xml | – name: Thailand |
| GrantInformation_xml | – fundername: Targeted Research Grant funderid: TR54101 – fundername: Thailand Research Fund – fundername: Khon Kaen University funderid: KKU56‐58 – fundername: a Mid‐Career Grant funderid: RSA5280007 – fundername: Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program funderid: PHD/0185/2552 – fundername: Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, through the Health Cluster (SHeP‐GMS) Khon Kaen University – fundername: Invitation Research Grant funderid: I56127 – fundername: Faculty of Medicine funderid: AS56202 |
| GroupedDBID | --- -Y2 0R~ 0VY 1OC 2JY 2~H 30V 33P 3SF 4.4 52U 52V 53G 5VS 8-1 8TC 8UJ 95. AAESR AAEVG AAHQN AAIAL AAIPD AAMMB AAMNL AANHP AANLZ AANXM AAONW AARHV AARTL AASGY AAXRX AAYCA AAYZH AAZKR ABCUV ABFSG ABJNI ABJOX ABQSL ABQWH ABXGK ACAHQ ACBWZ ACBXY ACCZN ACGFS ACGOF ACMXC ACOMO ACPOU ACREN ACRPL ACSTC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADHKG ADIZJ ADKPE ADKYN ADMGS ADNMO ADOZA ADQRH ADRFC ADXAS ADZMN AEFGJ AEGNC AEIGN AEIMD AENEX AEUYR AEYWJ AEZWR AFBBN AFBPY AFEXP AFFPM AFGKR AFHIU AFLOW AFWTZ AFWVQ AGHNM AGJBK AGQPQ AGXDD AGYGG AHBTC AHBYD AHKAY AHMBA AHSBF AHWEU AIACR AIDQK AIDYY AITYG AIURR AIXLP ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMKLP AMTXH AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BGNMA BHBCM BMXJE BRXPI BSCLL C45 CSCUP DCZOG DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN EN4 F5P FEDTE FUBAC G-S GODZA GQ8 H.X HF~ HGLYW HMJXF HVGLF HZ~ IZIGR JBSCW KBYEO LATKE LEEKS LH4 LITHE LOXES LUTES LYRES M4Y MA- MEWTI MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N2Q NF~ NU0 O66 O9- O93 O9I OVD P2W P9S PQQKQ Q.N QB0 QOS R89 ROL RSV S37 S3B SDE SMD SOJ SUPJJ SV3 TEORI TSV TUC VC2 WBKPD WHWMO WIH WIJ WIK WK8 WOHZO WVDHM WXSBR Z45 -5E -5G -BR AAHHS ABTEG ACCFJ ADINQ AEEZP AEQDE AFPWT AIWBW AJBDE GQ6 SZN Z7U Z82 Z87 Z8V ~EX AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
| ID | FETCH-LOGICAL-c4775-7daebf1bea648b68414e9b2615c2db6d34e770138dc0a4c249d2a5c640e5fd773 |
| ISSN | 1868-6974 1868-6982 |
| IngestDate | Fri Sep 05 07:58:16 EDT 2025 Fri Jul 25 07:44:33 EDT 2025 Thu Apr 03 07:01:18 EDT 2025 Wed Oct 01 06:33:56 EDT 2025 Thu Apr 24 23:08:09 EDT 2025 Wed Jan 22 16:42:32 EST 2025 Tue Sep 09 05:31:26 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Keywords | Serum miR-192 Opisthorchis viverrini Prognostic indicator Cholangiocarcinoma |
| Language | English |
| License | http://doi.wiley.com/10.1002/tdm_license_1.1 2014 Japanese Society of Hepato-Biliary-Pancreatic Surgery. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c4775-7daebf1bea648b68414e9b2615c2db6d34e770138dc0a4c249d2a5c640e5fd773 |
| Notes | a Mid-Career Grant - No. RSA5280007 istex:3F074AD750B8178E2D893AF4440C711B90454D80 Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, through the Health Cluster (SHeP-GMS) Khon Kaen University Targeted Research Grant - No. TR54101 Faculty of Medicine - No. AS56202 ArticleID:JHBP145 Khon Kaen University - No. KKU56-58 Thailand Research Fund ark:/67375/WNG-M572SVHK-C Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program - No. PHD/0185/2552 Invitation Research Grant - No. I56127 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| PMID | 25131257 |
| PQID | 1775514430 |
| PQPubID | 2034613 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_1627078317 proquest_journals_1775514430 pubmed_primary_25131257 crossref_citationtrail_10_1002_jhbp_145 crossref_primary_10_1002_jhbp_145 wiley_primary_10_1002_jhbp_145_JHBP145 istex_primary_ark_67375_WNG_M572SVHK_C |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | December 2014 |
| PublicationDateYYYYMMDD | 2014-12-01 |
| PublicationDate_xml | – month: 12 year: 2014 text: December 2014 |
| PublicationDecade | 2010 |
| PublicationPlace | Japan |
| PublicationPlace_xml | – name: Japan – name: Tokyo |
| PublicationTitle | Journal of hepato-biliary-pancreatic sciences |
| PublicationTitleAlternate | J Hepatobiliary Pancreat Sci |
| PublicationYear | 2014 |
| Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
| References | Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu Rev Med. 2009;60:167-179. Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y, et al. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer. 2013;108:644-652. Yongvanit P, Pinlaor S, Bartsch H. Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis. Parasitol Int. 2012;61:130-135. Hasebe T, Sasaki S, Imoto S, Ochiai A. Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast. Mod Pathol. 2001;14:325-337. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513-10518. Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, et al. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett. 2012;316:196-203. Sriamporn S, Pisani P, Pipitgool V, Suwanrungruang K, Kamsa-ard S, Parkin DM. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health. 2004;9:588-594. Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Kayashima T, Sakai H, et al. MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma. Ann Surg Oncol. 2010;17:3120-3128. Silsirivanit A, Araki N, Wongkham C, Pairojkul C, Narimatsu Y, Kuwahara K, et al. A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma. Cancer. 2011;117:3393-3403. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997-1006. Chen L, Yan HX, Yang W, Hu L, Yu LX, Liu Q, et al. The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol. 2009;50:358-369. Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology. 2011;54:1767-1776. Khan SA, Miras A, Pelling M, Taylor-Robinson SD. Cholangiocarcinoma and its management. Gut. 2007;56:1755-1756. Wongkham S, Silsirivanit A. State of serum markers for detection of cholangiocarcinoma. Asian Pac J Cancer Prev. 2012;13(Suppl):17-27. Chusorn P, Namwat N, Loilome W, Techasen A, Pairojkul C, Khuntikeo N, et al. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis. Tumour Biol. 2013;34:1579-1588. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut. 2009;58:1375-1381. Braconi C, Huang N, Patel T. MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology. 2010;51:881-890. Selaru FM, Olaru AV, Kan T, David S, Cheng Y, Mori Y, et al. MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology. 2009;49:1595-1601. Chamadol N, Pairojkul C, Khuntikeo N, Laopaiboon V, Loilome W, Sithithaworn P, et al. Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients. J Hepatobiliary Pancreat Sci. 2014;21:316-322. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology. 2006;130:2113-2129. Zhao C, Zhang J, Zhang S, Yu D, Chen Y, Liu Q, et al. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. Oncol Rep. 2013;30:276-284. Matsumoto S, Sakata Y, Suna S, Nakatani D, Usami M, Hara M, et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res. 2013;113:322-326. Zhang J, Han C, Wu T. MicroRNA-26a promotes cholangiocarcinoma growth by activating beta-catenin. Gastroenterology. 2012;143:246-256. Sripa B, Brindley PJ, Mulvenna J, Laha T, Smout MJ, Mairiang E, et al. The tumorigenic liver fluke Opisthorchis viverrini-multiple pathways to cancer. Trends Parasitol. 2012;28:395-407. Chung AC, Huang XR, Meng X, Lan HY. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol. 2010;21:1317-1325. Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol. 2011;29:4781-4788. Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199-227. Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene. 2008;27:378-386. Chen ZH, Zhang GL, Li HR, Luo JD, Li ZX, Chen GM, et al. A panel of five circulating microRNAs as potential biomarkers for prostate cancer. Prostate. 2012;72:1443-1452. Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS ONE. 2009;4:e5532. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297. Levy C, Lymp J, Angulo P, Gores GJ, Larusso N, Lindor KD. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig Dis Sci. 2005;50:1734-1740. Hausler SF, Keller A, Chandran PA, Ziegler K, Zipp K, Heuer S, et al. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer. 2010;103:693-700. Bamrungphon W, Prempracha N, Bunchu N, Rangdaeng S, Sandhu T, Srisukho S, et al. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma. Cancer Lett. 2007;247:301-308. Dechakhamphu S, Pinlaor S, Sitthithaworn P, Bartsch H, Yongvanit P. Accumulation of miscoding etheno-DNA adducts and highly expressed DNA repair during liver fluke-induced cholangiocarcinogenesis in hamsters. Mutat Res. 2010;691:9-16. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol. 2011;6:482-488. Luzna P, Gregar J, Uberall I, Radova L, Prochazka V, Ehrmann J, Jr. Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals. Diagn Pathol. 2011;6:114. Jin Z, Selaru FM, Cheng Y, Kan T, Agarwal R, Mori Y, et al. MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene. 2011;30:1577-1585. 2012; 61 2007; 247 2012; 143 2011; 117 2013; 108 2009; 60 2010; 17 2008; 18 2010; 103 2004; 9 2006; 130 2011; 30 2011; 54 2008; 105 2012; 13 2011; 6 2007; 56 2009; 49 2014; 21 2012; 72 2009; 58 2010; 21 2004; 116 2009; 50 2013; 34 2008; 27 2013; 30 2010; 691 2013; 113 2012; 28 2005; 50 2009; 4 2011; 29 2001; 14 2012; 316 2010; 51 Khan (10.1002/jhbp.145-BIB0003|jhbp145-cit-0003) 2007; 56 Wongkham (10.1002/jhbp.145-BIB0004|jhbp145-cit-0004) 2012; 13 Ng (10.1002/jhbp.145-BIB0015|jhbp145-cit-0015) 2009; 58 Tanaka (10.1002/jhbp.145-BIB0032|jhbp145-cit-0032) 2009; 4 Chen (10.1002/jhbp.145-BIB0017|jhbp145-cit-0017) 2012; 72 Sripa (10.1002/jhbp.145-BIB0034|jhbp145-cit-0034) 2012; 28 Meng (10.1002/jhbp.145-BIB0022|jhbp145-cit-0022) 2008; 27 Chamadol (10.1002/jhbp.145-BIB0002|jhbp145-cit-0002) 2014; 21 Zhao (10.1002/jhbp.145-BIB0028|jhbp145-cit-0028) 2013; 30 Bamrungphon (10.1002/jhbp.145-BIB0006|jhbp145-cit-0006) 2007; 247 Silsirivanit (10.1002/jhbp.145-BIB0007|jhbp145-cit-0007) 2011; 117 Garzon (10.1002/jhbp.145-BIB0010|jhbp145-cit-0010) 2009; 60 Foss (10.1002/jhbp.145-BIB0014|jhbp145-cit-0014) 2011; 6 Matsumoto (10.1002/jhbp.145-BIB0029|jhbp145-cit-0029) 2013; 113 Lee (10.1002/jhbp.145-BIB0009|jhbp145-cit-0009) 2009; 4 Sriamporn (10.1002/jhbp.145-BIB0001|jhbp145-cit-0001) 2004; 9 Zhang (10.1002/jhbp.145-BIB0024|jhbp145-cit-0024) 2012; 143 Bartel (10.1002/jhbp.145-BIB0008|jhbp145-cit-0008) 2004; 116 Dechakhamphu (10.1002/jhbp.145-BIB0025|jhbp145-cit-0025) 2010; 691 Hausler (10.1002/jhbp.145-BIB0016|jhbp145-cit-0016) 2010; 103 Liu (10.1002/jhbp.145-BIB0031|jhbp145-cit-0031) 2012; 316 Yongvanit (10.1002/jhbp.145-BIB0033|jhbp145-cit-0033) 2012; 61 Jin (10.1002/jhbp.145-BIB0035|jhbp145-cit-0035) 2011; 30 Hasebe (10.1002/jhbp.145-BIB0038|jhbp145-cit-0038) 2001; 14 Mitchell (10.1002/jhbp.145-BIB0011|jhbp145-cit-0011) 2008; 105 Zhou (10.1002/jhbp.145-BIB0013|jhbp145-cit-0013) 2011; 29 Takeshita (10.1002/jhbp.145-BIB0027|jhbp145-cit-0027) 2013; 108 Meng (10.1002/jhbp.145-BIB0018|jhbp145-cit-0018) 2006; 130 Ikenaga (10.1002/jhbp.145-BIB0026|jhbp145-cit-0026) 2010; 17 Chusorn (10.1002/jhbp.145-BIB0020|jhbp145-cit-0020) 2013; 34 Chung (10.1002/jhbp.145-BIB0037|jhbp145-cit-0037) 2010; 21 Levy (10.1002/jhbp.145-BIB0005|jhbp145-cit-0005) 2005; 50 Luzna (10.1002/jhbp.145-BIB0036|jhbp145-cit-0036) 2011; 6 Braconi (10.1002/jhbp.145-BIB0023|jhbp145-cit-0023) 2010; 51 Chen (10.1002/jhbp.145-BIB0021|jhbp145-cit-0021) 2009; 50 Chen (10.1002/jhbp.145-BIB0012|jhbp145-cit-0012) 2008; 18 Starkey Lewis (10.1002/jhbp.145-BIB0030|jhbp145-cit-0030) 2011; 54 Selaru (10.1002/jhbp.145-BIB0019|jhbp145-cit-0019) 2009; 49 |
| References_xml | – reference: Bamrungphon W, Prempracha N, Bunchu N, Rangdaeng S, Sandhu T, Srisukho S, et al. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma. Cancer Lett. 2007;247:301-308. – reference: Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513-10518. – reference: Chamadol N, Pairojkul C, Khuntikeo N, Laopaiboon V, Loilome W, Sithithaworn P, et al. Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients. J Hepatobiliary Pancreat Sci. 2014;21:316-322. – reference: Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut. 2009;58:1375-1381. – reference: Wongkham S, Silsirivanit A. State of serum markers for detection of cholangiocarcinoma. Asian Pac J Cancer Prev. 2012;13(Suppl):17-27. – reference: Silsirivanit A, Araki N, Wongkham C, Pairojkul C, Narimatsu Y, Kuwahara K, et al. A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma. Cancer. 2011;117:3393-3403. – reference: Yongvanit P, Pinlaor S, Bartsch H. Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis. Parasitol Int. 2012;61:130-135. – reference: Sripa B, Brindley PJ, Mulvenna J, Laha T, Smout MJ, Mairiang E, et al. The tumorigenic liver fluke Opisthorchis viverrini-multiple pathways to cancer. Trends Parasitol. 2012;28:395-407. – reference: Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y, et al. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer. 2013;108:644-652. – reference: Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS ONE. 2009;4:e5532. – reference: Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology. 2006;130:2113-2129. – reference: Zhao C, Zhang J, Zhang S, Yu D, Chen Y, Liu Q, et al. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. Oncol Rep. 2013;30:276-284. – reference: Luzna P, Gregar J, Uberall I, Radova L, Prochazka V, Ehrmann J, Jr. Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals. Diagn Pathol. 2011;6:114. – reference: Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene. 2008;27:378-386. – reference: Sriamporn S, Pisani P, Pipitgool V, Suwanrungruang K, Kamsa-ard S, Parkin DM. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health. 2004;9:588-594. – reference: Khan SA, Miras A, Pelling M, Taylor-Robinson SD. Cholangiocarcinoma and its management. Gut. 2007;56:1755-1756. – reference: Hausler SF, Keller A, Chandran PA, Ziegler K, Zipp K, Heuer S, et al. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer. 2010;103:693-700. – reference: Braconi C, Huang N, Patel T. MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology. 2010;51:881-890. – reference: Levy C, Lymp J, Angulo P, Gores GJ, Larusso N, Lindor KD. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig Dis Sci. 2005;50:1734-1740. – reference: Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu Rev Med. 2009;60:167-179. – reference: Chusorn P, Namwat N, Loilome W, Techasen A, Pairojkul C, Khuntikeo N, et al. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis. Tumour Biol. 2013;34:1579-1588. – reference: Chen L, Yan HX, Yang W, Hu L, Yu LX, Liu Q, et al. The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol. 2009;50:358-369. – reference: Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol. 2011;6:482-488. – reference: Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297. – reference: Dechakhamphu S, Pinlaor S, Sitthithaworn P, Bartsch H, Yongvanit P. Accumulation of miscoding etheno-DNA adducts and highly expressed DNA repair during liver fluke-induced cholangiocarcinogenesis in hamsters. Mutat Res. 2010;691:9-16. – reference: Matsumoto S, Sakata Y, Suna S, Nakatani D, Usami M, Hara M, et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res. 2013;113:322-326. – reference: Selaru FM, Olaru AV, Kan T, David S, Cheng Y, Mori Y, et al. MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology. 2009;49:1595-1601. – reference: Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Kayashima T, Sakai H, et al. MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma. Ann Surg Oncol. 2010;17:3120-3128. – reference: Hasebe T, Sasaki S, Imoto S, Ochiai A. Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast. Mod Pathol. 2001;14:325-337. – reference: Jin Z, Selaru FM, Cheng Y, Kan T, Agarwal R, Mori Y, et al. MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene. 2011;30:1577-1585. – reference: Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997-1006. – reference: Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, et al. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett. 2012;316:196-203. – reference: Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology. 2011;54:1767-1776. – reference: Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol. 2011;29:4781-4788. – reference: Chen ZH, Zhang GL, Li HR, Luo JD, Li ZX, Chen GM, et al. A panel of five circulating microRNAs as potential biomarkers for prostate cancer. Prostate. 2012;72:1443-1452. – reference: Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199-227. – reference: Chung AC, Huang XR, Meng X, Lan HY. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol. 2010;21:1317-1325. – reference: Zhang J, Han C, Wu T. MicroRNA-26a promotes cholangiocarcinoma growth by activating beta-catenin. Gastroenterology. 2012;143:246-256. – volume: 105 start-page: 10513 year: 2008 end-page: 10518 article-title: Circulating microRNAs as stable blood‐based markers for cancer detection publication-title: Proc Natl Acad Sci U S A – volume: 61 start-page: 130 year: 2012 end-page: 135 article-title: Oxidative and nitrative DNA damage: key events in opisthorchiasis‐induced carcinogenesis publication-title: Parasitol Int – volume: 130 start-page: 2113 year: 2006 end-page: 2129 article-title: Involvement of human micro‐RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines publication-title: Gastroenterology – volume: 30 start-page: 276 year: 2013 end-page: 284 article-title: Diagnostic and biological significance of microRNA‐192 in pancreatic ductal adenocarcinoma publication-title: Oncol Rep – volume: 4 start-page: e5532 year: 2009 article-title: Down‐regulation of miR‐92 in human plasma is a novel marker for acute leukemia patients publication-title: PLoS ONE – volume: 49 start-page: 1595 year: 2009 end-page: 1601 article-title: MicroRNA‐21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 publication-title: Hepatology – volume: 54 start-page: 1767 year: 2011 end-page: 1776 article-title: Circulating microRNAs as potential markers of human drug‐induced liver injury publication-title: Hepatology – volume: 103 start-page: 693 year: 2010 end-page: 700 article-title: Whole blood‐derived miRNA profiles as potential new tools for ovarian cancer screening publication-title: Br J Cancer – volume: 18 start-page: 997 year: 2008 end-page: 1006 article-title: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases publication-title: Cell Res – volume: 51 start-page: 881 year: 2010 end-page: 890 article-title: MicroRNA‐dependent regulation of DNA methyltransferase‐1 and tumor suppressor gene expression by interleukin‐6 in human malignant cholangiocytes publication-title: Hepatology – volume: 113 start-page: 322 year: 2013 end-page: 326 article-title: Circulating p53‐responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction publication-title: Circ Res – volume: 50 start-page: 1734 year: 2005 end-page: 1740 article-title: The value of serum CA 19‐9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis publication-title: Dig Dis Sci – volume: 58 start-page: 1375 year: 2009 end-page: 1381 article-title: Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening publication-title: Gut – volume: 116 start-page: 281 year: 2004 end-page: 297 article-title: MicroRNAs: genomics, biogenesis, mechanism, and function publication-title: Cell – volume: 108 start-page: 644 year: 2013 end-page: 652 article-title: Serum microRNA expression profile: miR‐1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma publication-title: Br J Cancer – volume: 21 start-page: 1317 year: 2010 end-page: 1325 article-title: miR‐192 mediates TGF‐beta/Smad3‐driven renal fibrosis publication-title: J Am Soc Nephrol – volume: 316 start-page: 196 year: 2012 end-page: 203 article-title: Genome‐wide microRNA profiles identify miR‐378 as a serum biomarker for early detection of gastric cancer publication-title: Cancer Lett – volume: 9 start-page: 588 year: 2004 end-page: 594 article-title: Prevalence of infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand publication-title: Trop Med Int Health – volume: 50 start-page: 358 year: 2009 end-page: 369 article-title: The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma publication-title: J Hepatol – volume: 14 start-page: 325 year: 2001 end-page: 337 article-title: Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast publication-title: Mod Pathol – volume: 29 start-page: 4781 year: 2011 end-page: 4788 article-title: Plasma microRNA panel to diagnose hepatitis B virus‐related hepatocellular carcinoma publication-title: J Clin Oncol – volume: 143 start-page: 246 year: 2012 end-page: 256 article-title: MicroRNA‐26a promotes cholangiocarcinoma growth by activating beta‐catenin publication-title: Gastroenterology – volume: 117 start-page: 3393 year: 2011 end-page: 3403 article-title: A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma publication-title: Cancer – volume: 17 start-page: 3120 year: 2010 end-page: 3128 article-title: MicroRNA‐203 expression as a new prognostic marker of pancreatic adenocarcinoma publication-title: Ann Surg Oncol – volume: 60 start-page: 167 year: 2009 end-page: 179 article-title: MicroRNAs in cancer publication-title: Annu Rev Med – volume: 691 start-page: 9 year: 2010 end-page: 16 article-title: Accumulation of miscoding etheno‐DNA adducts and highly expressed DNA repair during liver fluke‐induced cholangiocarcinogenesis in hamsters publication-title: Mutat Res – volume: 4 start-page: 199 year: 2009 end-page: 227 article-title: MicroRNAs in cancer publication-title: Annu Rev Pathol – volume: 247 start-page: 301 year: 2007 end-page: 308 article-title: A new mucin antibody/enzyme‐linked lectin‐sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma publication-title: Cancer Lett – volume: 30 start-page: 1577 year: 2011 end-page: 1585 article-title: MicroRNA‐192 and ‐215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro publication-title: Oncogene – volume: 34 start-page: 1579 year: 2013 end-page: 1588 article-title: Overexpression of microRNA‐21 regulating PDCD4 during tumorigenesis of liver fluke‐associated cholangiocarcinoma contributes to tumor growth and metastasis publication-title: Tumour Biol – volume: 28 start-page: 395 year: 2012 end-page: 407 article-title: The tumorigenic liver fluke Opisthorchis viverrini–multiple pathways to cancer publication-title: Trends Parasitol – volume: 27 start-page: 378 year: 2008 end-page: 386 article-title: Epigenetic regulation of microRNA‐370 by interleukin‐6 in malignant human cholangiocytes publication-title: Oncogene – volume: 72 start-page: 1443 year: 2012 end-page: 1452 article-title: A panel of five circulating microRNAs as potential biomarkers for prostate cancer publication-title: Prostate – volume: 6 start-page: 114 year: 2011 article-title: Changes of microRNAs‐192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals publication-title: Diagn Pathol – volume: 13 start-page: 17 issue: Suppl year: 2012 end-page: 27 article-title: State of serum markers for detection of cholangiocarcinoma publication-title: Asian Pac J Cancer Prev – volume: 21 start-page: 316 year: 2014 end-page: 322 article-title: Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients publication-title: J Hepatobiliary Pancreat Sci – volume: 6 start-page: 482 year: 2011 end-page: 488 article-title: miR‐1254 and miR‐574‐5p: serum‐based microRNA biomarkers for early‐stage non‐small cell lung cancer publication-title: J Thorac Oncol – volume: 56 start-page: 1755 year: 2007 end-page: 1756 article-title: Cholangiocarcinoma and its management publication-title: Gut – volume: 21 start-page: 316 year: 2014 ident: 10.1002/jhbp.145-BIB0002|jhbp145-cit-0002 article-title: Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients publication-title: J Hepatobiliary Pancreat Sci doi: 10.1002/jhbp.64 – volume: 4 start-page: e5532 year: 2009 ident: 10.1002/jhbp.145-BIB0032|jhbp145-cit-0032 article-title: Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients publication-title: PLoS ONE doi: 10.1371/journal.pone.0005532 – volume: 27 start-page: 378 year: 2008 ident: 10.1002/jhbp.145-BIB0022|jhbp145-cit-0022 article-title: Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes publication-title: Oncogene doi: 10.1038/sj.onc.1210648 – volume: 316 start-page: 196 year: 2012 ident: 10.1002/jhbp.145-BIB0031|jhbp145-cit-0031 article-title: Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer publication-title: Cancer Lett doi: 10.1016/j.canlet.2011.10.034 – volume: 4 start-page: 199 year: 2009 ident: 10.1002/jhbp.145-BIB0009|jhbp145-cit-0009 article-title: MicroRNAs in cancer publication-title: Annu Rev Pathol doi: 10.1146/annurev.pathol.4.110807.092222 – volume: 113 start-page: 322 year: 2013 ident: 10.1002/jhbp.145-BIB0029|jhbp145-cit-0029 article-title: Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction publication-title: Circ Res doi: 10.1161/CIRCRESAHA.113.301209 – volume: 9 start-page: 588 year: 2004 ident: 10.1002/jhbp.145-BIB0001|jhbp145-cit-0001 article-title: Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand publication-title: Trop Med Int Health doi: 10.1111/j.1365-3156.2004.01234.x – volume: 58 start-page: 1375 year: 2009 ident: 10.1002/jhbp.145-BIB0015|jhbp145-cit-0015 article-title: Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening publication-title: Gut doi: 10.1136/gut.2008.167817 – volume: 72 start-page: 1443 year: 2012 ident: 10.1002/jhbp.145-BIB0017|jhbp145-cit-0017 article-title: A panel of five circulating microRNAs as potential biomarkers for prostate cancer publication-title: Prostate doi: 10.1002/pros.22495 – volume: 50 start-page: 358 year: 2009 ident: 10.1002/jhbp.145-BIB0021|jhbp145-cit-0021 article-title: The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma publication-title: J Hepatol doi: 10.1016/j.jhep.2008.09.015 – volume: 61 start-page: 130 year: 2012 ident: 10.1002/jhbp.145-BIB0033|jhbp145-cit-0033 article-title: Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis publication-title: Parasitol Int doi: 10.1016/j.parint.2011.06.011 – volume: 103 start-page: 693 year: 2010 ident: 10.1002/jhbp.145-BIB0016|jhbp145-cit-0016 article-title: Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening publication-title: Br J Cancer doi: 10.1038/sj.bjc.6605833 – volume: 30 start-page: 276 year: 2013 ident: 10.1002/jhbp.145-BIB0028|jhbp145-cit-0028 article-title: Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma publication-title: Oncol Rep doi: 10.3892/or.2013.2420 – volume: 247 start-page: 301 year: 2007 ident: 10.1002/jhbp.145-BIB0006|jhbp145-cit-0006 article-title: A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma publication-title: Cancer Lett doi: 10.1016/j.canlet.2006.05.007 – volume: 116 start-page: 281 year: 2004 ident: 10.1002/jhbp.145-BIB0008|jhbp145-cit-0008 article-title: MicroRNAs: genomics, biogenesis, mechanism, and function publication-title: Cell doi: 10.1016/S0092-8674(04)00045-5 – volume: 105 start-page: 10513 year: 2008 ident: 10.1002/jhbp.145-BIB0011|jhbp145-cit-0011 article-title: Circulating microRNAs as stable blood-based markers for cancer detection publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0804549105 – volume: 28 start-page: 395 year: 2012 ident: 10.1002/jhbp.145-BIB0034|jhbp145-cit-0034 article-title: The tumorigenic liver fluke Opisthorchis viverrini-multiple pathways to cancer publication-title: Trends Parasitol doi: 10.1016/j.pt.2012.07.006 – volume: 6 start-page: 114 year: 2011 ident: 10.1002/jhbp.145-BIB0036|jhbp145-cit-0036 article-title: Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals publication-title: Diagn Pathol doi: 10.1186/1746-1596-6-114 – volume: 30 start-page: 1577 year: 2011 ident: 10.1002/jhbp.145-BIB0035|jhbp145-cit-0035 article-title: MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro publication-title: Oncogene doi: 10.1038/onc.2010.534 – volume: 50 start-page: 1734 year: 2005 ident: 10.1002/jhbp.145-BIB0005|jhbp145-cit-0005 article-title: The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis publication-title: Dig Dis Sci doi: 10.1007/s10620-005-2927-8 – volume: 17 start-page: 3120 year: 2010 ident: 10.1002/jhbp.145-BIB0026|jhbp145-cit-0026 article-title: MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma publication-title: Ann Surg Oncol doi: 10.1245/s10434-010-1188-8 – volume: 14 start-page: 325 year: 2001 ident: 10.1002/jhbp.145-BIB0038|jhbp145-cit-0038 article-title: Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast publication-title: Mod Pathol doi: 10.1038/modpathol.3880310 – volume: 130 start-page: 2113 year: 2006 ident: 10.1002/jhbp.145-BIB0018|jhbp145-cit-0018 article-title: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines publication-title: Gastroenterology doi: 10.1053/j.gastro.2006.02.057 – volume: 54 start-page: 1767 year: 2011 ident: 10.1002/jhbp.145-BIB0030|jhbp145-cit-0030 article-title: Circulating microRNAs as potential markers of human drug-induced liver injury publication-title: Hepatology doi: 10.1002/hep.24538 – volume: 51 start-page: 881 year: 2010 ident: 10.1002/jhbp.145-BIB0023|jhbp145-cit-0023 article-title: MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes publication-title: Hepatology doi: 10.1002/hep.23381 – volume: 60 start-page: 167 year: 2009 ident: 10.1002/jhbp.145-BIB0010|jhbp145-cit-0010 article-title: MicroRNAs in cancer publication-title: Annu Rev Med doi: 10.1146/annurev.med.59.053006.104707 – volume: 6 start-page: 482 year: 2011 ident: 10.1002/jhbp.145-BIB0014|jhbp145-cit-0014 article-title: miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer publication-title: J Thorac Oncol doi: 10.1097/JTO.0b013e318208c785 – volume: 108 start-page: 644 year: 2013 ident: 10.1002/jhbp.145-BIB0027|jhbp145-cit-0027 article-title: Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma publication-title: Br J Cancer doi: 10.1038/bjc.2013.8 – volume: 21 start-page: 1317 year: 2010 ident: 10.1002/jhbp.145-BIB0037|jhbp145-cit-0037 article-title: miR-192 mediates TGF-beta/Smad3-driven renal fibrosis publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2010020134 – volume: 34 start-page: 1579 year: 2013 ident: 10.1002/jhbp.145-BIB0020|jhbp145-cit-0020 article-title: Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis publication-title: Tumour Biol doi: 10.1007/s13277-013-0688-0 – volume: 18 start-page: 997 year: 2008 ident: 10.1002/jhbp.145-BIB0012|jhbp145-cit-0012 article-title: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases publication-title: Cell Res doi: 10.1038/cr.2008.282 – volume: 56 start-page: 1755 year: 2007 ident: 10.1002/jhbp.145-BIB0003|jhbp145-cit-0003 article-title: Cholangiocarcinoma and its management publication-title: Gut doi: 10.1136/gut.2007.138859 – volume: 13 start-page: 17 issue: Suppl year: 2012 ident: 10.1002/jhbp.145-BIB0004|jhbp145-cit-0004 article-title: State of serum markers for detection of cholangiocarcinoma publication-title: Asian Pac J Cancer Prev – volume: 29 start-page: 4781 year: 2011 ident: 10.1002/jhbp.145-BIB0013|jhbp145-cit-0013 article-title: Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma publication-title: J Clin Oncol doi: 10.1200/JCO.2011.38.2697 – volume: 117 start-page: 3393 year: 2011 ident: 10.1002/jhbp.145-BIB0007|jhbp145-cit-0007 article-title: A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma publication-title: Cancer doi: 10.1002/cncr.25912 – volume: 143 start-page: 246 year: 2012 ident: 10.1002/jhbp.145-BIB0024|jhbp145-cit-0024 article-title: MicroRNA-26a promotes cholangiocarcinoma growth by activating beta-catenin publication-title: Gastroenterology doi: 10.1053/j.gastro.2012.03.045 – volume: 49 start-page: 1595 year: 2009 ident: 10.1002/jhbp.145-BIB0019|jhbp145-cit-0019 article-title: MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 publication-title: Hepatology doi: 10.1002/hep.22838 – volume: 691 start-page: 9 year: 2010 ident: 10.1002/jhbp.145-BIB0025|jhbp145-cit-0025 article-title: Accumulation of miscoding etheno-DNA adducts and highly expressed DNA repair during liver fluke-induced cholangiocarcinogenesis in hamsters publication-title: Mutat Res doi: 10.1016/j.mrfmmm.2010.06.003 |
| SSID | ssj0000313930 |
| Score | 2.3399148 |
| Snippet | Background
This study aimed to investigate the miR‐192 levels in patients' sera of liver fluke‐associated cholangiocarcinoma (CCA) for a prospective prognostic... This study aimed to investigate the miR-192 levels in patients' sera of liver fluke-associated cholangiocarcinoma (CCA) for a prospective prognostic indicator.... Background This study aimed to investigate the miR-192 levels in patients' sera of liver fluke-associated cholangiocarcinoma (CCA) for a prospective prognostic... This study aimed to investigate the miR-192 levels in patients' sera of liver fluke-associated cholangiocarcinoma (CCA) for a prospective prognostic... |
| SourceID | proquest pubmed crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 864 |
| SubjectTerms | Animals Bile Duct Neoplasms - blood Bile Duct Neoplasms - genetics Bile Duct Neoplasms - parasitology Bile Ducts, Intrahepatic - parasitology Biomarkers, Tumor - blood Cholangiocarcinoma Cholangiocarcinoma - blood Cholangiocarcinoma - genetics Cholangiocarcinoma - parasitology Confidence intervals Female Humans Male Mesocricetus MicroRNAs - blood MicroRNAs - genetics Middle Aged Opisthorchiasis - blood Opisthorchiasis - genetics Opisthorchiasis - parasitology Opisthorchis Opisthorchis viverrini Prognosis Prognostic indicator Prospective Studies Real-Time Polymerase Chain Reaction Serum miR-192 Thailand |
| Title | Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator |
| URI | https://api.istex.fr/ark:/67375/WNG-M572SVHK-C/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjhbp.145 https://www.ncbi.nlm.nih.gov/pubmed/25131257 https://www.proquest.com/docview/1775514430 https://www.proquest.com/docview/1627078317 |
| Volume | 21 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1868-6982 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000313930 issn: 1868-6974 databaseCode: AFBBN dateStart: 19970301 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lc9owENZQuPTSaacv2rTjznTogVFqZPnVW2BCmTShmQQabh5ZFsEN2NTgvv5x_0VXlm1MQp8X2yNrsOT92P1WXu0i9BI4BqEGszDvGBxTrhvYFcTGvg_kVhBOXSYX9E-G1mBMjybmpFb7UYlaStf-Pv--c1_J_0gV2kCucpfsP0i2_FFogGuQLxxBwnD8Kxn3woRn5bfA3V-EZxh4lFy_mMtYi_Z0nl4JzPLXD7wyc2OjyxCsV8LDKF6wIqvqSm15BmVabLzM4raiWCZxbsuv2pyprMS7iOwMLNo6xjLKliXfMKgXxUR5OzevJW0_D-dAWDO1f5bK6iFfKhFBcTjPS7ZfgHmYgQ8fbVRSdPlZ5unIOG8KkwDcbgIT0lWsQpJP4QwgFAmrLmZ06LXAkD-rzIqqdiwHW66q8bMvqm3Oln5XO7ALHJOKtnZUAvUbVkRlpf0485dgSMyNpSyiA4bvvf74-NgbHU5G23cVMQAfkloGzK-1_IRlgTMZCJBXe7mFGsS2LFJHjYN-tzssFwRlEk03q41TzqxIlqyT18VgtuhTQ2qCr7t8o21XK-NKo7voTo4N7UAh9h6qieg-WlTQquVo1cJIy9CqXUerdhOtWoHWNxpcb7CqbbCqlVh9gMb9w1FvgPNiH5hT2zaxHTDhTzu-YBZ1fMuhHSpcH_x7k5PAtwKDCtuWn9UDrjPKCXUDwkxuUV2Y08C2jYeoHsWReIw0oMjCmLKp6-ucdgTxZQ5H6BgwO5g6AWuiV8U79HieCV8WZJl7Koc38eTbBqfYbKIXZc-lyv6yo08rE0PZgSVXMlrSNr2L4VvvxLTJ-YfBO6_XRHuFnLxciay8DswdfBZq6PCs8jaoePndjkUiTqGPRWROLmD6TfRIybd8GLgnBvgocKeVCfyXw_SOBt1TOD_5_Sieotub_-Ueqq-TVDwD2r32n-eA_Qlg4eIA |
| linkProvider | Library Specific Holdings |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Circulating+miR-192+in+liver+fluke-associated+cholangiocarcinoma+patients%3A+a+prospective+prognostic+indicator&rft.jtitle=Journal+of+hepato-biliary-pancreatic+sciences&rft.au=Silakit%2C+Runglawan&rft.au=Loilome%2C+Watcharin&rft.au=Yongvanit%2C+Puangrat&rft.au=Chusorn%2C+Porncheera&rft.date=2014-12-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1868-6974&rft.eissn=1868-6982&rft.volume=21&rft.issue=12&rft.spage=864&rft_id=info:doi/10.1002%2Fjhbp.145&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3996463201 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1868-6974&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1868-6974&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1868-6974&client=summon |